A Clinician's Perspective on Some of the Challenges in "Closing the Loop"

Diabetes Technology and Therapeutics

Volumn 5, Issue 5, 2003, Pages 843-846

  Wolpert, Howard A ^a  

^a JOSLIN DIABETES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ACCURACY; BLOOD GLUCOSE MONITORING; DIABETES MELLITUS; DRUG DELIVERY SYSTEM; FOOD INTAKE; GLUCOSE HOMEOSTASIS; HUMAN; INFUSION PUMP; MEDICAL DECISION MAKING; NOTE; PRIORITY JOURNAL; RELIABILITY;

ATTITUDE OF HEALTH PERSONNEL; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; HUMANS; INSULIN INFUSION SYSTEMS; MONITORING, PHYSIOLOGIC;

EID: 0242300689     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/152091503322527049     Document Type: Note

References (15)

1. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986.
2. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;354:837-853.
3. Wolpert HA, ed: Smart Pumping: A Practical Approach to Mastering the Insulin Pump. Alexandria, VA: American Diabetes Association, 2002.
4. Abel PU, Von Woedtke T: Biosensors for in vivo glucose measurement: can we cross the experimental phase. Biosens Bioelectron 2002;17:1059-1070.
5. Thompson JS, Duckworth WC: Insulin pump and glucose regulation. World J Surg 2001;25:523-526.
6. Furnary AP, Zerr KJ, Grunkmeier GL, Starr A: Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgery procedures. Ann Thorac Surg 1999;67:352-362.
7. Malmberg K, for the DIGAMI (Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group: Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. BMJ 1997;314:1512-1515.
8. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R: Intensive insulin therapy in critically ill patients. N Engl J Med 2001;345:1359-1367.
9. Monsod TP, Flanagan DE, Rife F, Saenz R, Caprio S, Sherwin RS, Tamborlane WV: Do sensor glucose levels accurately predict glucose concentrations during hypoglycemia and hyperinsulinemia? Diabetes Care 2002;25:889-893.
10. Aussedat B, Dupire-Angel M, Gifford R, Klein JC, Wilson GS, Reach G: Interstitial glucose concentration and glycemia: implications for continuous subcutaneous glucose monitoring. Am J Physiol Endocrinol Metab 2000;278:E716-E728.
11. Koschinsky T, Heinemann L: Sensors for glucose monitoring: technical and clinical aspects. Diabetes Metab Res Rev 2001;17:113-123.
12. Fischer U, Hommel H, Ziegler M, Michael R: The mechanism of insulin secretion after oral glucose. Diabetologia 1972;8:104-110.
13. Aarnio P, Lauritsen T, Dela F: Insulin secretion and glucose kinetics in exercise with and without pharmacological alpha(1)- and alpha(2)-receptor blockade. Diabetologia 2001;50:1834-1843.
14. Moberg E, Kollind M, Lins PE, Adamson U: Acute mental stress impairs insulin sensitivity in IDDM patients. Diabetologia 1994;37:247-251.
15. Choleau C, Dokladal P, Klein J-C, Ward WK, Wilson GS, Reach G: Prevention of hypoglycemia using risk asssessment with a continuous glucose monitoring system. Diabetes 2002;51:3263-3273.